We continue to see enormous technological and scientific progress in the area of drug discovery, with the promise of AI to upend traditional models and approaches becoming more fully realized by the ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

For AI to deliver meaningful value, organizations need more than clean data. They need timely data. The FDA has published a ...

Clinical Trial Data Management II (45 minutes): The goal of the workshop is to provide practical examples of data management concepts in the context of clinical trials. Attendees will see how to apply ...

BCC Research examines how AI is streamlining patient recruitment, optimizing trial design, enabling remote monitoring and improving data quality across decentralized clinical trials.”Boston, July 01, ...

The clinical trials arena is becoming increasingly data-driven, with demand growing for sponsors to have real-time data access and ongoing updates throughout a study rather than just a final report.

A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has synergized the impacts of worldwide ...

Sitaram Srivatsavai, senior director and head of engineering for product suites, IQVIA, explores how the right AI strategy can unlock faster, smarter financial operations.

Why is tokenization important for the future of medicine development? A tremendous amount of data is collected throughout a clinical trial, but prior to tokenization, the life science industry did not ...

Protocol amendments are almost a given in complex oncology trials. When one biotech sponsor’s Phase Ib/II clinical trial needed a major revision with several amendments, its CRO, Catalyst Clinical ...

Thermo Fisher (NYSE:TMO) is nearing a takeover of Clario in an all-cash deal that could value the clinical trial data management firm at around $10B, the Financial Times reported, citing people ...